April 28 Webinar: Bad Ads Program
The pharmaceutical industry spends nearly three times as much on advertising to health care professionals as it does on advertising to consumers.
Responsible promotional efforts can give health care professionals valuable information about the latest drug treatments. But not all promotions are accurate and balanced.
Through its Bad Ads Program, the Food and Drug Administration (FDA) asks health care professionals for help in making sure the promotion of prescription drugs is not false or misleading.
Learn how the Bad Ads Program helps protect the public during a 30-minute webinar.
An opportunity to ask questions will follow the presentation.
When: Thursday, April 28, 12:00 p.m. (ET)
Length: 30 minutes
Where: To join the webinar, see the instructions at www.fda.gov/AboutFDA/Transparency/Basics/ucm249817.htm
Host: Division of Drug Marketing, Advertising, and Communication within FDA’s Center for Drug Evaluation and Research
Featured speaker: Catherine Gray, Pharm.D., of the Division of Drug Marketing, Advertising, and Communication within FDA’s Center for Drug Evaluation and Research.
This webinar is part of a series of online sessions hosted by different FDA centers and offices. The series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.
This article appears on FDA's Consumer Updates page, which features the latest on all FDA-regulated products.
April 21, 2011